Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-11-02

Clinical Trial Update: An Observational Study on The Correlation Between Time of Initiation of Avastin (Bevacizumab) Treatment And Progression-Free Survival in Patients With Metastatic Breast Cancer (CRONOS 2)

View source ↗

Summary

An observational study evaluating whether the time of initiation of Bevacizumab (Avastin) treatment affects progression-free survival in metastatic breast cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Status: TERMINATED